rs17266594 — BANK1 Branch-point splice

Intronic branch-point variant in BANK1 that shifts isoform balance toward full-length protein with intact TIR domain, amplifying TLR-driven B-cell activation and raising risk for SLE and systemic sclerosis

See your personal result for BANK1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

BANK1 Branch-Point Splice Variant — When One Intron Controls Two Inflammatory Pathways

BANK1 (B-cell scaffold protein with ankyrin repeats 1) is expressed almost exclusively in B cells, where it orchestrates two interconnected arms of immune signaling: B-cell receptor (BCR) activation11 B-cell receptor (BCR) activation
BANK1 scaffolds LYN kinase, IP3 receptors, and PLCγ2 into a complex that mobilizes calcium from the endoplasmic reticulum upon antigen engagement and toll-like receptor (TLR) signaling22 toll-like receptor (TLR) signaling
BANK1 full-length isoform contains a TIR domain in exon 2 that directly binds the TLR adaptor MyD88, linking BANK1 to innate immune pattern-recognition signaling in B cells. The rs17266594 variant sits in intron 1 of BANK1 at the branch-point sequence — a short RNA motif that the spliceosome uses to determine whether exon 2 is included in the mature mRNA. This single intronic change controls which of two BANK1 proteins a B cell predominantly produces, with downstream consequences for both BCR and TLR arms of B-cell activation.

The Mechanism

Alternative splicing of BANK1 produces two isoforms: the full-length (FL) protein that retains exon 2, and the Delta2 (Δ2) isoform that skips exon 2 entirely. Exon 2 encodes a Toll/IL-1 receptor (TIR) domain33 Toll/IL-1 receptor (TIR) domain
The TIR domain is a conserved protein interaction module found in toll-like receptors and their adaptors; it mediates signal propagation through homotypic TIR-TIR interactions — the same class of domain that enables MyD88 to propagate signals from TLR7 and TLR9 after recognition of viral RNA and DNA.

The rs17266594 variant alters the branch-point consensus sequence immediately upstream of exon 2. The T allele (risk) shifts the isoform balance toward full-length BANK144 T allele (risk) shifts the isoform balance toward full-length BANK1
T allele correlates with higher FL:Δ2 ratio; C allele correlates with higher Δ2 expression in homozygous protective carriers, meaning T carriers produce proportionally more TIR-domain-containing BANK1. The C allele (protective) promotes exon 2 skipping, favoring the Δ2 isoform that lacks the TIR domain.

The functional consequence is mechanistically clear: BANK1-Δ2, lacking the TIR domain, shows significantly reduced binding to MyD8855 BANK1-Δ2, lacking the TIR domain, shows significantly reduced binding to MyD88
Co-immunoprecipitation experiments demonstrated markedly decreased BANK1-Δ2 interaction with MyD88 compared to BANK1-FL, confirming the TIR domain is essential for this interaction compared to full-length BANK1. This matters because TLR7 and TLR9 in B cells drive interferon-alpha production and autoantibody generation — the molecular signature of active SLE. When BANK1-FL dominates (T allele), B cells have a stronger TLR-MyD88 signaling axis, amplifying innate immune responses that can break self-tolerance. When BANK1-Δ2 dominates (C allele), this TLR arm is dampened.

rs17266594 is in strong linkage disequilibrium with rs10516487 (R61H) — r²=0.9 in Europeans and r²=1 in Chinese populations — meaning they are nearly always coinherited. The SLE risk haplotype is TGG across rs17266594-rs10516487-rs3733197, while the protective haplotype is CAA. Despite near-complete LD, the two SNPs affect distinct molecular processes: rs10516487 modifies scaffolding complex multimerization and SRp40 splicing enhancer activity, while rs17266594 affects branch-point recognition. Together they constitute a coordinated isoform-control mechanism.

The Evidence

The variant was co-discovered with rs10516487 and rs3733197 in the original BANK1 genome-wide association study66 original BANK1 genome-wide association study
Kozyrev et al. used 85,042 SNPs across European SLE cases and controls, identifying rs17266594 as a branch-point splice variant with differential isoform expression dependent on this SNP. In a dedicated European-ancestry replication study of 1,892 SLE cases and 2,652 controls, rs17266594 showed the strongest association signal77 rs17266594 showed the strongest association signal
Despite being intronic, rs17266594 produced the strongest BANK1-SLE signal in this cohort: corrected P=1.97×10⁻⁵, OR=1.22 (95% CI 1.12–1.34) among all BANK1 variants tested — a notable finding for a non-coding SNP.

Replication across ancestries is robust. In Hong Kong Chinese88 Hong Kong Chinese
949 SLE cases, 1,042 controls; the protective C allele OR=0.61 (95% CI 0.51–0.72), P=4.67×10⁻⁹, with r²=1 LD with rs10516487 in HapMap HCB Chinese, the association was stronger than in Europeans. In Chinese Han patients, the T allele was enriched among SLE patients and was significantly associated with high-titre ANA and anti-SSA antibodies99 significantly associated with high-titre ANA and anti-SSA antibodies
Among BANK1 variant carriers with SLE, rs17266594 T allele showed specific enrichment for ANA ≥1:320 and Ro/SSA autoantibodies — autoantibody specificities that mark active, organ-threatening disease.

A meta-analysis of 22 studies1010 meta-analysis of 22 studies
Bae and Lee 2017; 22,684 patients and 36,437 controls across SLE, RA, and SSc; BANK1 rs17266594 T allele pooled OR=1.19 (95% CI 1.07–1.32), P=0.001 across all autoimmune diseases confirmed the disease-specific pattern: significant association for SLE (OR=1.41) and systemic sclerosis (OR=1.09), but no significant RA association — distinguishing rs17266594 from rs3733197 (A383T), which does associate with RA when the BLK risk background is also present.

B-cell functional studies showed that individuals carrying the BANK1 risk haplotype (TGG) have altered proximal BCR signaling1111 altered proximal BCR signaling
Risk haplotype carriers show reduced phospho-PLCγ2 and phospho-AKT, increased FOXO1 expression, and expanded memory B-cell compartment — a pro-autoimmune B-cell developmental bias, with expanded memory B cells and blunted immediate BCR activation markers, consistent with a B-cell population primed for autoantibody differentiation over acute antigen response.

Practical Actions

Carrying the TT genotype means your BANK1 produces predominantly the full-length isoform with intact TIR domain, giving your B cells enhanced responsiveness to both BCR stimulation and TLR7/TLR9 ligands such as viral RNA and DNA. This does not cause autoimmune disease independently — environmental triggers (UV light, viral infections, estrogen cycling), HLA haplotype, and other BANK1 and BLK variants are all required co-factors. Most T allele carriers will never develop SLE or SSc. However, the variant meaningfully shifts probability, and early recognition of symptoms — malar rash, persistent joint pain, Raynaud's phenomenon, persistent dry mouth or eyes, photosensitivity — warrants prompt rheumatologic evaluation rather than watchful waiting.

Because rs17266594 and rs10516487 are in near-complete LD, their clinical implications substantially overlap: both tag the same risk haplotype in most individuals. Where they differ is in Chinese populations (r²=1) where rs17266594 is the sole independent tag needed, and in the specific mechanism it illuminates — the TLR-MyD88 axis — which has direct therapeutic relevance. Belimumab (anti-BAFF) and hydroxychloroquine remain the best-evidenced interventions for SLE once diagnosed, regardless of BANK1 genotype. However, the TLR-MyD88 connection suggests that TLR7/TLR9 antagonists (under clinical development for SLE) may be particularly relevant for T allele carriers.

Interactions

rs17266594 is nearly always coinherited with rs10516487 (R61H) as part of the BANK1 risk haplotype TGG (rs17266594-rs10516487-rs3733197). The two SNPs affect distinct molecular mechanisms — branch-point splicing versus SRp40 splicing enhancer and protein multimerization — but their effects converge on the same phenotype (increased full-length:Δ2 isoform ratio and amplified B-cell activation). When interpreting these two SNPs, genotype concordance is expected in most people; a rare discordant individual (TC at rs17266594, GG at rs10516487) may have partially additive effects.

The BLK rs13277113 variant (reduced BLK expression in B cells) shows documented gene-gene interaction with BANK1 variants1212 documented gene-gene interaction with BANK1 variants
BLK and BANK1 gene-gene interaction confirmed by logistic regression (P=0.013), MDR (P<0.0001), and linear regression (P=0.0017) in SLE susceptibility — when risk alleles at both loci are present, the combined SLE risk substantially exceeds individual contributions. Similarly, STAT4 rs7574865 (amplified JAK-STAT interferon signaling) compounds with BANK1 variants because the TLR-MyD88-IFN-α axis activated by full-length BANK1 feeds directly into the STAT4 pathway. Individuals carrying risk alleles at rs17266594 (or rs10516487), rs13277113, and rs7574865 simultaneously represent the highest-risk genetic tier for SLE among the SNPs in this database.

Genotype Interpretations

What each possible genotype means for this variant.

CC Δ2 Isoform Favored Normal

Homozygous protective — BANK1 Δ2 isoform dominates, dampening TLR-driven B-cell activation

You carry two copies of the C allele at rs17266594 — the protective genotype. Your branch-point sequence promotes exon 2 skipping, so your B cells predominantly produce the BANK1 Δ2 isoform lacking the TIR domain. This reduces MyD88 binding and blunts TLR7/TLR9-driven interferon-alpha production in B cells. The CC genotype is associated with the lowest BANK1-mediated SLE risk among the three genotypes. It is found in approximately 9% of people globally, and is more common in Europeans (~10%) and East Asians (~3%). Your autoimmune risk from this specific BANK1 variant is at or below population average.

CT Intermediate Splice Balance Intermediate

One T risk allele — modestly elevated SLE and SSc susceptibility through partial isoform shift

In the additive inheritance model that best fits BANK1 rs17266594, heterozygous TC individuals have approximately half the excess risk of TT homozygotes. The meta-analytic OR of 1.22 per T allele translates to approximately 1.22× baseline risk for TC carriers and 1.22² ≈ 1.49× for TT carriers. The absolute baseline risk of SLE in the general population is approximately 0.1–0.2% (1 in 500–1000 people), so these relative risk increases remain small in absolute terms for most individuals.

The TC genotype is particularly relevant if other BANK1 (rs10516487, rs3733197) or BLK (rs13277113) risk alleles are also present, since the risk haplotype TGG (rs17266594-rs10516487- rs3733197) amplifies the effect. In Chinese populations where r²=1 between rs17266594 and rs10516487, the TC genotype is typically accompanied by heterozygosity at rs10516487, making the combined interpretation straightforward.

TT Full-Length BANK1 Dominant High Risk

Homozygous risk — BANK1 isoform balance strongly shifts toward TLR-amplified B-cell activation

The TT genotype at rs17266594 maintains the branch-point sequence in its "non-disruptive" form, allowing efficient inclusion of exon 2 during BANK1 mRNA splicing. The resulting protein retains the TIR domain — a signaling module that binds MyD88 downstream of TLR7 and TLR9. This connection is clinically important: TLR7 responds to single-stranded RNA (including self-RNA released from dying cells), and TLR9 responds to unmethylated CpG DNA — both pattern-recognition receptors that drive the interferon-alpha production and autoantibody generation characteristic of active SLE.

In functional B-cell studies, individuals carrying the BANK1 risk haplotype (which includes the T allele at rs17266594) show a distinctive B-cell phenotype: expanded memory B cells, reduced immediate BCR signaling markers, but enhanced susceptibility to TLR-driven activation. This paradox — blunted acute BCR signal yet enhanced TLR responsiveness — may explain why BANK1 risk carriers develop predominantly autoantibody-driven disease rather than impaired antigen-specific responses.

SLE risk from this variant is highest in combination with BLK rs13277113 (reduced B-cell tolerance) and STAT4 rs7574865 (amplified interferon signaling). Environmental triggers matter: UV light releases self-DNA from keratinocytes, activating TLR9; viral infections provide TLR7 ligands; estrogens upregulate TLR7 expression, explaining the female predominance of SLE.